BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 32698732)

  • 41. Transient cortical blindness in COVID-19 pneumonia; a PRES-like syndrome: Case report.
    Kaya Y; Kara S; Akinci C; Kocaman AS
    J Neurol Sci; 2020 Jun; 413():116858. PubMed ID: 32387762
    [No Abstract]   [Full Text] [Related]  

  • 42. [Neurological Manifestations of COVID-19: Meningoencephalitis and Encephalopathy].
    Nakajima H
    Brain Nerve; 2020 Oct; 72(10):1031-1037. PubMed ID: 33051388
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19 and its impact on neurological manifestations and mental health: the present scenario.
    Sultana S; Ananthapur V
    Neurol Sci; 2020 Nov; 41(11):3015-3020. PubMed ID: 32865638
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Massive bilateral stroke in a COVID-19 patient.
    Mohamed IZB; Balson L; Madathil S
    BMJ Case Rep; 2020 Aug; 13(8):. PubMed ID: 32816935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Stroke as a complication and prognostic factor of COVID-19.
    Trejo-Gabriel-Galán JM
    Neurologia (Engl Ed); 2020 Jun; 35(5):318-322. PubMed ID: 32493597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Rare Axonal Variant of Guillain-Barré Syndrome as a Neurological Complication of COVID-19 Infection.
    Agha Abbaslou M; Karbasi M; Mozhdehipanah H
    Arch Iran Med; 2020 Oct; 23(10):718-721. PubMed ID: 33107316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neurological manifestations of COVID-19: a systematic review.
    Nepal G; Rehrig JH; Shrestha GS; Shing YK; Yadav JK; Ojha R; Pokhrel G; Tu ZL; Huang DY
    Crit Care; 2020 Jul; 24(1):421. PubMed ID: 32660520
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Highlights of Selected Articles July 2020.
    Romero JR
    Stroke; 2020 Jul; 51(7):1927. PubMed ID: 32568650
    [No Abstract]   [Full Text] [Related]  

  • 49. [Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care].
    Gusev EI; Martynov MY; Boyko AN; Voznyuk IA; Latsh NY; Sivertseva SA; Spirin NN; Shamalov NA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2020; 120(6):7-16. PubMed ID: 32678542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Central nervous system manifestations of COVID-19: A systematic review.
    Asadi-Pooya AA; Simani L
    J Neurol Sci; 2020 Jun; 413():116832. PubMed ID: 32299017
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
    Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
    J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Neurological complications in patients with SARS-CoV-2 infection: a systematic review.
    Munhoz RP; Pedroso JL; Nascimento FA; Almeida SM; Barsottini OGP; Cardoso FEC; Teive HAG
    Arq Neuropsiquiatr; 2020 May; 78(5):290-300. PubMed ID: 32490966
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review.
    Orrù G; Conversano C; Malloggi E; Francesconi F; Ciacchini R; Gemignani A
    Int J Environ Res Public Health; 2020 Sep; 17(18):. PubMed ID: 32937949
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Environmental Issues and Neurological Manifestations Associated with COVID-19 Pandemic: New Aspects of the Disease?
    Bellocchio L; Bordea IR; Ballini A; Lorusso F; Hazballa D; Isacco CG; Malcangi G; Inchingolo AD; Dipalma G; Inchingolo F; Piscitelli P; Logroscino G; Miani A
    Int J Environ Res Public Health; 2020 Nov; 17(21):. PubMed ID: 33139595
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Important and Unresolved Aspects of Neuropathologic Analyses of COVID-19 Individuals].
    Takao M
    Brain Nerve; 2020 Oct; 72(10):1061-1065. PubMed ID: 33051393
    [TBL] [Abstract][Full Text] [Related]  

  • 56. COVID-19 Infection and Neurological Complications: Present Findings and Future Predictions.
    Beghi E; Feigin V; Caso V; Santalucia P; Logroscino G
    Neuroepidemiology; 2020; 54(5):364-369. PubMed ID: 32610334
    [TBL] [Abstract][Full Text] [Related]  

  • 57. COVID-19 and stroke-A global World Stroke Organization perspective.
    Markus HS; Brainin M
    Int J Stroke; 2020 Jun; 15(4):361-364. PubMed ID: 32310017
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurologic aspects of covid-19: a concise review.
    Brouwer MC; Ascione T; Pagliano P
    Infez Med; 2020 Jun; 28(suppl 1):42-45. PubMed ID: 32532937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurological manifestations of COVID-19 and other coronavirus infections: A systematic review.
    Montalvan V; Lee J; Bueso T; De Toledo J; Rivas K
    Clin Neurol Neurosurg; 2020 Jul; 194():105921. PubMed ID: 32422545
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Stroke and COVID19: Not only a large-vessel disease.
    Frisullo G; Bellavia S; Scala I; Piano C; Morosetti R; Brunetti V; Calabresi P; Della Marca G
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105074. PubMed ID: 32912559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.